Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Curium strikes up to $8B deal for radiopharma rival Lantheus

Curium strikes up to $8B deal for radiopharma rival Lantheus

August 3, 2026Posted inMedical Technology

Months after reports first linked Curium to a potential Lantheus takeover, the radiopharma players have made it official with a deal worth up to $8 billion.

Post navigation

Previous Post
targeted-treatments-aim-to-improve-outcomes-for-serious-lung-infections Targeted Treatments Aim to Improve Outcomes for Serious Lung Infections
Next Post
Evolutionarily Diverse Organisms Switch Genes on Simply and Switch Them off Dynamically evolutionarily-diverse-organisms-switch-genes-on-simply-and-switch-them-off-dynamically

Recent Posts

  • New intelligence tracks solid-state batteries across their entire life cycle
  • AKR1B10 Serum Marker Aids Liver Cancer Diagnosis and Postoperative Monitoring
  • How Cytokine Signals from the Immune System Disrupt Brain Circuits
  • Cambridge scientist unveils Medicine 4.0 framework promoting wider access to ideas, services
  • USC Receives $3.2 Million NIH Grant to Study Age-Related Inflammation and Cancer

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top